To hear about similar clinical trials, please enter your email below
Trial Title:
Lung Cancer Screening Eligibility Assessment
NCT ID:
NCT06133816
Condition:
Lung Cancer
Conditions: Official terms:
Lung Neoplasms
Conditions: Keywords:
Lung Cancer Screening
Study type:
Interventional
Study phase:
N/A
Overall status:
Active, not recruiting
Study design:
Allocation:
Randomized
Intervention model:
Factorial Assignment
Intervention model description:
We will use a randomized factorial design to test the effects of different types of
messaging with or without incentives on response rates to an eligibility survey.
Primary purpose:
Health Services Research
Masking:
Single (Outcomes Assessor)
Intervention:
Intervention type:
Behavioral
Intervention name:
Framed Introductory Message A
Description:
Randomly assign patients to receive introductory message encouraging them to complete the
survey (version A).
Arm group label:
Arm 1 (Introductory Message A + Tobacco Use Message A + Incentive)
Arm group label:
Arm 2 (Introductory Message A + Tobacco Use Message A)
Arm group label:
Arm 3 (Introductory Message A + Tobacco Use Message B + Incentive)
Arm group label:
Arm 4 (Introductory Message A + Tobacco Use Message B)
Intervention type:
Behavioral
Intervention name:
Framed Introductory Message B
Description:
Randomly assign patients to receive introductory message encouraging them to complete the
survey (version B).
Arm group label:
Arm 5 (Introductory Message B + Tobacco Use Message A + Incentive)
Arm group label:
Arm 6 (Introductory Message B + Tobacco Use Message A)
Arm group label:
Arm 7 (Introductory Message B + Tobacco Use Message B + Incentive)
Arm group label:
Arm 8 (Introductory Message B + Tobacco Use Message B)
Intervention type:
Behavioral
Intervention name:
Framed Introductory Message C
Description:
Randomly assign patients to receive introductory message encouraging them to complete the
survey (version C).
Arm group label:
Arm 10 (Introductory Message C + Tobacco Use Message A)
Arm group label:
Arm 11 (Introductory Message C + Tobacco Use Message B + Incentive)
Arm group label:
Arm 12 (Introductory Message C + Tobacco Use Message B)
Arm group label:
Arm 9 (Introductory Message C + Tobacco Use Message A + Incentive)
Intervention type:
Behavioral
Intervention name:
Framed Tobacco Use Message A
Description:
Randomly assign patients to receive norming message related to tobacco use (version A).
Arm group label:
Arm 1 (Introductory Message A + Tobacco Use Message A + Incentive)
Arm group label:
Arm 10 (Introductory Message C + Tobacco Use Message A)
Arm group label:
Arm 2 (Introductory Message A + Tobacco Use Message A)
Arm group label:
Arm 5 (Introductory Message B + Tobacco Use Message A + Incentive)
Arm group label:
Arm 6 (Introductory Message B + Tobacco Use Message A)
Arm group label:
Arm 9 (Introductory Message C + Tobacco Use Message A + Incentive)
Intervention type:
Behavioral
Intervention name:
Framed Tobacco Use Message B
Description:
Randomly assign patients to receive norming message related to tobacco use (version B).
Arm group label:
Arm 11 (Introductory Message C + Tobacco Use Message B + Incentive)
Arm group label:
Arm 12 (Introductory Message C + Tobacco Use Message B)
Arm group label:
Arm 3 (Introductory Message A + Tobacco Use Message B + Incentive)
Arm group label:
Arm 4 (Introductory Message A + Tobacco Use Message B)
Arm group label:
Arm 7 (Introductory Message B + Tobacco Use Message B + Incentive)
Arm group label:
Arm 8 (Introductory Message B + Tobacco Use Message B)
Intervention type:
Behavioral
Intervention name:
Financial Incentive
Description:
Randomly assigned patients to be entered into a drawing to receive a $100 gift card.
Arm group label:
Arm 1 (Introductory Message A + Tobacco Use Message A + Incentive)
Arm group label:
Arm 11 (Introductory Message C + Tobacco Use Message B + Incentive)
Arm group label:
Arm 3 (Introductory Message A + Tobacco Use Message B + Incentive)
Arm group label:
Arm 5 (Introductory Message B + Tobacco Use Message A + Incentive)
Arm group label:
Arm 7 (Introductory Message B + Tobacco Use Message B + Incentive)
Arm group label:
Arm 9 (Introductory Message C + Tobacco Use Message A + Incentive)
Summary:
The primary purpose of this study evaluate if different messaging impacts response rates
to a brief survey (i.e., the simplified eligibility tool) that is designed to estimate
pack-year eligibility for lung cancer screening (LCS). This will help inform the best way
to increase response rates to the tool in future intervention studies designed to
increase LCS, and expand upon survey methodology in general.
Detailed description:
Despite growing evidence that lung cancer screening (LCS) reduces lung cancer-specific
mortality, LCS across the United States is remarkably low. This is due in part to
challenges with identifying adults who meet eligibility criteria for lifetime smoking
intensity (i.e., 20 pack-years or greater), which is often missing from the electronic
medical record. We have developed a simplified eligibility tool that has shown accuracy
in estimating pack-years. But given the potential for low response rates, there is a
great need to identify effective strategies to increasing response rates equitably prior
to using it in practice or in future studies. The primary purpose of this study evaluate
if different messaging impacts response rates to a brief survey (i.e., the simplified
eligibility tool) that is designed to estimate pack-year eligibility for lung cancer
screening (LCS). This will help to identify the best way to increase response rates to
the tool in future intervention studies designed to increase LCS, and expand upon survey
methodology in general.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
1. meet age eligibility (50-80 years old) for LCS based on 2021 USPSTF guidelines; and
2. have completed at least one primary care visit at Penn Medicine in 2020-2025
Exclusion Criteria:
1. have a documented history of lung cancer;
2. have a documented history of completing LCS at Penn Medicine;
3. are listed as not wanting to be contacted or solicited for research; or
4. do not otherwise meet inclusion criteria.
Gender:
All
Minimum age:
50 Years
Maximum age:
80 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
University of Pennsylvania
Address:
City:
Philadelphia
Zip:
19104
Country:
United States
Start date:
July 31, 2023
Completion date:
December 31, 2027
Lead sponsor:
Agency:
Abramson Cancer Center at Penn Medicine
Agency class:
Other
Collaborator:
Agency:
National Institutes of Health (NIH)
Agency class:
NIH
Collaborator:
Agency:
National Cancer Institute (NCI)
Agency class:
NIH
Source:
Abramson Cancer Center at Penn Medicine
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06133816
